I PEACE INC.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
I Peace announces new iPSC lines to reduce immune rejection risk for U.S. population 2024-10-30 02:55
Stem Cell Therapy developers I Peace and iCamuno Biotherapeutics Start Natural Killer Cell Trial for Ovarian Cancer 2024-08-22 21:00
KOSÉ, I Peace, and Reju Enter Strategic Partnership to Develop Personalized Beauty Products Based on iPS Cells 2024-07-09 23:00
GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant 2024-01-31 05:46
GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant 2023-12-06 22:30
Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine 2023-11-02 00:00
I Peace, Inc. honored in BioSpectrum Asia Excellence Award 2022 with "Special Recognition in Cell Therapy" 2022-12-21 15:10
I Peace partners with the California Institute for Regenerative Medicine [CIRM] 2022-11-02 00:00
GMP cell CDMO I Peace, Inc. in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming 2022-09-21 05:39
I Peace accelerates allogeneic iPSC-derived cell therapies with a high throughput method to identify a large number of donors with specific HLA haplotypes. 2022-05-12 00:00
I Peace triples GMP cell manufacturing by expanding CDMO facility 2022-03-15 03:22
I Peace's Cell Manufacturing Facility "Peace Engine Kyoto" now registered as U.S. FDA Drug Establishment 2022-01-27 01:00
Koji Tanabe, CEO of I Peace, Inc. honored by World Biz Magazine with "Top 100 Innovation CEO" Award 2021-09-22 02:00
Stem Cells for Everyone: I Peace expands its clinical-grade iPSC banking service leveraging mass manufacturing capability 2021-09-08 02:00
I Peace's cell manufacturing facility "Peace Engine Kyoto" receives third-party certification as US cGMP compliant: the facility now meets the standard for both the US and Japanese markets 2021-05-26 03:00
I Peace, Inc. and Avery Therapeutics announce collaboration to bring iPSC derived cell therapy for heart failure to the clinic 2020-12-17 08:41
I Peace, Inc. Obtains IRB Approval for Production of Clinical and Research-Grade iPSCs for Commercial Use 2020-12-04 05:00
Stem Cells for Everyone: Revolutionizing Regenerative Medicine with Mass Manufacturing of Induced Pluripotent Stem Cells (iPSCs) 2020-07-16 00:00
I Peace, Inc. Begins Clinical-Grade Induced Pluripotent Stem Cells Custom Manufacturing Service 2020-05-16 01:00
1